Suchergebnisse - "Criscitiello, C"

PubPharm (19)

1

How I treat HER2-positive early breast cancer : how long adjuvant trastuzumab is needed?

enthalten in: ESMO open | 2022

von Morganti, S. | Bianchini, G. | Giordano, A. | +3

2

Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer : a systematic review

enthalten in: Breast cancer research and treatment | 2021

von Trapani, D. | Giugliano, F. | Uliano, J. | +8

3

Benefit of adjuvant chemotherapy in patients with lobular breast cancer : A systematic review of the literature and metanalysis

enthalten in: Cancer treatment reviews | 2021

von Trapani, D. | Gandini, S. | Corti, C. | +6

4

Impact of COVID-19 on social media as perceived by the oncology community : results from a survey in collaboration with the European Society for Medical Oncology (ESMO) and the OncoAlert Network

enthalten in: ESMO open | 2021

von Morgan, G. | Tagliamento, M. | Lambertini, M. | +15

5

Managing cancer patients during the COVID-19 pandemic : an ESMO multidisciplinary expert consensus

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Curigliano, G. | Banerjee, S. | Cervantes, A. | +76

6

Tumor-infiltrating lymphocytes (TILs) in ER+/HER2- breast cancer

enthalten in: Breast cancer research and treatment | 2020

von Criscitiello, C. | Vingiani, A. | Maisonneuve, P. | +3

7

Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Park, J. | Jonas, S. | Bataillon, G. | +11

CommentIn: Ann Oncol. 2019 Dec 1;30(12):1849-1850. - PMID 31626275

8

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer : TREnd trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Malorni, L. | Curigliano, G. | Minisini, A. | +19

9

The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer : Results from Neo-ALTTO

enthalten in: European journal of cancer (Oxford, England : 1990) | 2018

von Di Cosimo, S. | Campbell, C. | Azim, H. | +18

10

A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Criscitiello, C. | Bayar, M. | Curigliano, G. | +12